Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Marie Socha"'
Publikováno v:
Therapies. 77:777-778
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67d1b30d3530767055b60e5fc5babe8f
https://doi.org/10.1016/j.therap.2022.10.045
https://doi.org/10.1016/j.therap.2022.10.045
Publikováno v:
Therapies. 77:788
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::792b07d272d3cf84a83d84f8d0e4d91b
https://doi.org/10.1016/j.therap.2022.10.064
https://doi.org/10.1016/j.therap.2022.10.064
Autor:
Simona Radice, Maria Fazio, Marjorie Argollo, Marie Socha, Damien Loeuille, Ailsa Hart, Elena Vegni, Gionata Fiorino, Carmelo Carlo-Stella, Laurent Peyrin-Biroulet, Anthony Lopez, Silvio Danese, Stefanos Bonovas, Antonio Costanzo, Marien González-Lorenzo, Carlo Selmi, Fernando Magro, Daniela Gilardi, Lieven Pouillon
Publikováno v:
Alimentary Pharmacology & Therapeutics (Suppl)
Alimentary Pharmacology & Therapeutics (Suppl), 2019, 49 (9), pp.1181-1187. ⟨10.1111/apt.15223⟩
Alimentary Pharmacology & Therapeutics (Suppl), 2019, 49 (9), pp.1181-1187. ⟨10.1111/apt.15223⟩
Background The nocebo effect is a negative effect of a pharmacological or nonpharmacological medical treatment that is induced by patients' expectations, and that is unrelated to the physiological action of the treatment. The nocebo effect can negati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0a954b75dec0a8b7cfebb2c2910b2bd
https://doi.org/10.1111/apt.15223
https://doi.org/10.1111/apt.15223
Autor:
Lieven Pouillon, Vered Abitbol, Béatrice Demoré, Silvio Danese, Laurent Peyrin-Biroulet, Nathalie Thilly, Marie Socha
Publikováno v:
Expert Review of Clinical Immunology
Expert Review of Clinical Immunology, Expert Reviews (formerly Future Drugs), 2018, 14 (9), pp.739-749. ⟨10.1080/1744666X.2018.1512406⟩
Expert Review of Clinical Immunology, Expert Reviews (formerly Future Drugs), 2018, 14 (9), pp.739-749. ⟨10.1080/1744666X.2018.1512406⟩
The nocebo effect is defined as a negative effect of a pharmacological or non-pharmacological medical treatment that is induced by patients' expectations, and that is unrelated to the physiological action of the treatment. The nocebo effect is an imp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5783f9977180ec28f890a59cc57599c6
https://doi.org/10.1080/1744666x.2018.1512406
https://doi.org/10.1080/1744666x.2018.1512406
Autor:
Hervé Javelot, Marie Socha, Catherine Guerrier, Anne Didelot, Jean-Pierre Pelte, Sandrine Fritsch, Nicolas Didelot
Publikováno v:
Soins Pédiatrie/Puériculture. 37:35-40
Based on an assessment of adverse events in a follow-up care and rehabilitation unit in paediatrics, audits were carried out of the medicine use pathway. The evaluation grid taken from this study today serves as a basis for the audits carried out on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1df5b70e56110f63b4d65ff696ac34b5
https://doi.org/10.1016/j.spp.2016.03.012
https://doi.org/10.1016/j.spp.2016.03.012
Spray-dried microparticles of glutathione and S-nitrosoglutathione based on Eudragit® FS 30D polymer
Publikováno v:
Annales Pharmaceutiques Françaises
Annales Pharmaceutiques Françaises, Elsevier Masson, 2017, 75 (2), pp.95-104. ⟨10.1016/j.pharma.2016.09.001⟩
Annales Pharmaceutiques Françaises, Elsevier Masson, 2017, 75 (2), pp.95-104. ⟨10.1016/j.pharma.2016.09.001⟩
Summary Objective In recent years, S-nitrosoglutathione has been proposed for the treatment of Crohn's disease to prevent mucosal barrier failure. In this paper, we report the formulation of spray dried microparticles of glutathione and S-nitrosoglut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799acc75a61bce8647109d66b6e16f54
https://hal.univ-lorraine.fr/hal-01875168
https://hal.univ-lorraine.fr/hal-01875168
Autor:
N. Didelot, Luisa Weiner, C. Glay-Ribau, Michaël Messaoudi, B. Kabuth, Hervé Javelot, F. Body-Lawson, F. Ligier, Marie Socha
Publikováno v:
Annales Pharmaceutiques Françaises. 72:164-177
Summary Introduction Psychotimulant-antipyschotic combinations are frequently used in child psychiatry, but have been rarely described in the literature. Method and patients We propose here a retrospective study of 44 children who received the combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c4d3c40782f2f7477fd0b0a58bcf52b
https://doi.org/10.1016/j.pharma.2013.12.009
https://doi.org/10.1016/j.pharma.2013.12.009
Autor:
Nadine Petitpain, Anne Marquis, Marie Socha, Bruno Michel, Hervé Javelot, Nicolas Didelot, Thierry Javelot
Publikováno v:
Alternative and Complementary Therapies
Alternative and Complementary Therapies, Mary Ann Liebert, 2016, 71 (3), pp.347-348. ⟨10.1016/j.therap.2015.11.007⟩
Alternative and Complementary Therapies, Mary Ann Liebert, 2016, 71 (3), pp.347-348. ⟨10.1016/j.therap.2015.11.007⟩
Nous rapportons le cas d’une femme âgee de 89 ans qui a presente un probable syndrome de sevrage aigu apres l’arret d’un traitement antalgique de 7 jours par tramadol. La patiente avait une insuffisante renale moderee.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52cc60ee214930f4226ba714ae22d979
https://hal.archives-ouvertes.fr/hal-02923668
https://hal.archives-ouvertes.fr/hal-02923668
Autor:
Nicolas, Didelot, Catherine, Guerrier, Anne, Didelot, Sandrine, Fritsch, Jean-Pierre, Pelte, Marie, Socha, Hervé, Javelot
Publikováno v:
Soins. Pediatrie, puericulture. (290)
Based on an assessment of adverse events in a follow-up care and rehabilitation unit in paediatrics, audits were carried out of the medicine use pathway. The evaluation grid taken from this study today serves as a basis for the audits carried out on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da86c5870ac91f20442efe56faeaa8ce
https://pubmed.ncbi.nlm.nih.gov/27177486
https://pubmed.ncbi.nlm.nih.gov/27177486
Publikováno v:
Drug Delivery
Drug Delivery, Taylor & Francis, 2016, 23 (8), pp.2927-2935. ⟨10.3109/10717544.2015.1122676⟩
Drug Delivery, Taylor & Francis, 2016, 23 (8), pp.2927-2935. ⟨10.3109/10717544.2015.1122676⟩
S-nitrosothiols are a class of NO-donors currently under investigation for the treatment of various diseases. In this study, we developed a novel NO-donor (S-nitrosoglutathione-alginate, SNA) by cross-linking alginate with S-nitrosothiols, which can
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6a652b1809c33e84420de9441543140
https://pubmed.ncbi.nlm.nih.gov/26666370
https://pubmed.ncbi.nlm.nih.gov/26666370